Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin Jean–François Rossignol, Asem Elfert,

Slides:

Advertisements

Similar presentations

Hepatitis web study Hepatitis web study Simeprevir in Genotype 1 (Viral Relapsers) PROMISE Trial Phase 3 Treatment Experienced Forns X, et al. Gastroenterology.

Advertisements

Volume 149, Issue 6, Pages (November 2015)

Rapid virological response tailors the duration of treatment in hepatitis C virus genotype 3 patients treated with pegylated interferon alfa-2a and ribavirin.

Report of an International Workshop: Roadmap for Management of Patients Receiving Oral Therapy for Chronic Hepatitis B Emmet B. Keeffe, Stefan Zeuzem,

Volume 152, Issue 4, Pages (March 2017)

Christoph Lübbert, Babett Holler Gastroenterology

Covering the Cover Gastroenterology

Volume 149, Issue 6, Pages (November 2015)

Identification of the Best Direct-Acting Antiviral Regimen for Patients With Hepatitis C Virus Genotype 3 Infection: A Systematic Review and Network Meta-analysis

New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges

Effectiveness of Hepatitis B Treatment in Clinical Practice

A Patient With Left Upper Abdominal Pain Who Had Petit Sac

Is HCV Infection a Neurologic Disorder?

Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection Tobias Boettler, Robert Thimme Gastroenterology

Peginterferon alfa-2b plus ribavirin for chronic hepatitis

Ira J. Fox, Stephen C. Strom Gastroenterology

Gastroenterology 2011–2016: Looking Back and Forward

Volume 138, Issue 2, Pages e1 (February 2010)

Clinical Challenges and Images in GI

Volume 140, Issue 2, Pages e1 (February 2011)

Unusual Case of an Upset Stomach

Volume 135, Issue 4, Pages (October 2008)

A Historical Perspective on Clinical Advances in Pancreatic Diseases

Volume 150, Issue 4, Pages (April 2016)

Volume 146, Issue 3, Pages e3 (March 2014)

Report of an International Workshop: Roadmap for Management of Patients Receiving Oral Therapy for Chronic Hepatitis B Emmet B. Keeffe, Stefan Zeuzem,

Volume 154, Issue 4, Pages (March 2018)

An Unusual Incidental Finding in a Patient With Colon Perforation

Volume 155, Issue 5, Pages e2 (November 2018)

Jean-Michel Pawlotsky Gastroenterology

Volume 138, Issue 1, Pages (January 2010)

Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill

Volume 142, Issue 6, Pages (May 2012)

Laura Rotundo, Sushil Ahlawat Gastroenterology

Ingmar Mederacke, Michael P. Manns, Bernhard Meyer Gastroenterology

Coffee and Colorectal Cancer: Grounds for Prevention?

Rafael Esteban, Maria Buti Gastroenterology

Volume 133, Issue 2, Pages (August 2007)

Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease Markus.

Volume 150, Issue 7, Pages (June 2016)

Recurrent Hematochezia in a Patient With Chronic Constipation

Ashwin N. Ananthakrishnan, David Lieberman Gastroenterology

Volume 154, Issue 4, Pages (March 2018)

Volume 148, Issue 3, Pages (March 2015)

Presentation of the Julius M. Friedenwald Medal to Emmet B. Keeffe, MD

Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6

Genetic Factors and Hepatitis C Virus Infection

Jeremy P. Dwyer, Patrick Hosking, John Lubel Gastroenterology

Volume 149, Issue 6, Pages (November 2015)

Volume 150, Issue 7, Pages (June 2016)

Alan Bonder, MD, Nezam H. Afdhal, MD

Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C Gowtham A. Rao, Prashant K. Pandya Gastroenterology

The Dawning of a New Editorial Board for Gastroenterology

Alessio Aghemo, Maria Francesca Donato Gastroenterology

Volume 156, Issue 4, Pages (March 2019)

Volume 132, Issue 1, Pages (January 2007)

Changing of the Guards: 2011–2016 Gastroenterology Team

Volume 156, Issue 4, Pages (March 2019)

Volume 156, Issue 3, Pages (February 2019)

Volume 155, Issue 6, Pages (December 2018)

Volume 139, Issue 6, Pages e1 (December 2010)

Volume 139, Issue 5, Pages (November 2010)

Volume 137, Issue 6, Pages (December 2009)

Volume 138, Issue 6, Pages (May 2010)

Reinvesting in US Biomedical Research—The Time is Now

Volume 135, Issue 2, Pages (August 2008)

Electronic Clinical Challenges and Images in GI

Controversies in Liver Transplantation for Hepatitis C

The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus.

Volume 156, Issue 4, Pages (March 2019)

Presentation transcript:

Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin Jean–François Rossignol, Asem Elfert, Yehia El–Gohary, Emmet B. Keeffe Gastroenterology Volume 136, Issue 3, Pages 856-862 (March 2009) DOI: 10.1053/j.gastro.2008.11.037 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Study design. NTZ, nitazoxanide 500 mg twice daily; Peg-IFN alfa-2a, peginterferon alfa-2a 180 μg/wk. Gastroenterology 2009 136, 856-862DOI: (10.1053/j.gastro.2008.11.037) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Patient disposition flowchart. NTZ, nitazoxanide 500 mg twice daily; PegIFN, peginterferon alfa-2a 180 μg/wk; RBV, ribavirin 1000–1200 mg/day. Gastroenterology 2009 136, 856-862DOI: (10.1053/j.gastro.2008.11.037) Copyright © 2009 AGA Institute Terms and Conditions